No Detail Found!

Evaluation of clinical efficacy of Chemotherapy for Rhabdomyosarcoma in children

Author(s)
Zhaohui Ning Department of Traditional Chinese Medicine, Taian City Central Hospital,Shandong, 271000, China.
Xiping Liu Department of Tumor Minimally Invasive, Taian City Central Hospital,Taian, Shandong, 271000,China
Guang Qin Department of Oncology, Taian City Central Hospital,Taian, Shandong, 271000,China
Lei Wei Department of Traditional Chinese Medicine, Taian City Central Hospital,Shandong, 271000, China
Xia Li Department of Pediatric, Taian City Central Hospital,Taian, Shandong, 271000,China
Jingjing Shen Department of Pediatric,Taian City Central Hospital,Taian, Shandong, 271000,China
Abstract
Objective: To investigate the clinical characteristics and treatment methods of rhabdomyosarcoma in children and the efficacy of the methods. Methods: The clinical data of 30 children with rhabdomyosarcoma who were admitted to our hospital from August 2013 to August 2017 were retrospectively analyzed. The clinical characteristics were summarized, and the curative effect and prognosis were evaluated. Results: Among all the children (N=30), there were 20 males and 10 females, with a median age of 3.5 years. As to the primary site, there were 13 cases of head and neck, 11 cases of trunk, three cases of urogenital system and three cases of limbs. There were 25 cases of embryonic type, 4 cases of alveolar type and one case of polymorphic type. As regards clinical stage, there were one case of stage I, 9 cases of stage II, 13 cases of stage III and 7 cases of stage IV. There were one case of low risk, 19 cases of medium risk and 10 cases of high risk. Eight cases received surgery alone, 22 cases received combined treatment of surgery and chemotherapy (the chemotherapeutics followed three schemes, low-risk group (VAC+VA), moderate risk group (VAC) and high risk group (alternating use of VDC and IE). Among all the cases (N=30), there were 14 cases of complete remission (CR), five cases of partial remission (PR), four cases of stable disease (SD), and 7 cases of progressive disease (PD). The CR rate was (N=14, 46.7%). The three-year overall survival (OS) rate was (N=19, 63.3%). The clinical efficacy and prognosis of children receiving surgery and chemotherapy were better than those of children receiving surgery alone, and the difference was statistically significant (P<0.05). Conclusion: Rhabdomyosarcoma in children frequently happens in the head, neck and trunk. Embryonic type is the main pathological type of rhabdomyosarcoma. Comprehensive and standardized treatment based on surgery and chemotherapy is an important way to improve the curative effect in the treatment of rhabdomyosarcoma in children.
Publication Details
Page(s) 1069-1074
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 36, Issue: 5, Year: 2020

Request the full text from PASTIC

0

Citations

0

Downloads

227

Views